Categories: Awareness

WHO congratulates India for significantly reducing child deaths

By Dr Poonam Khetrapal Singh, WHO Regional Director for South-East Asia

WHO commends India for its concerted efforts to reduce child deaths, which have resulted in under-five mortality estimates to have fallen below the one million mark.

As outlined in a report released by the UN Inter-agency Group for Child Mortality Estimation, India’s share of global child deaths has been reduced from 22% in 2012 to 18% in 2017 ­– a rate that outpaces the global decline.

India’s remarkable achievement was made possible via a series of initiatives the Ministry of Health and Family Welfare has taken in recent years, including to vaccinate each and every child with life-saving vaccines under Mission Indradhanush and to expand the reach of diarrhea and pneumonia management across the country, with a focus on vulnerable and hard-to-reach populations.

Given recent reductions, the global percentage of under-five deaths that occur in India is commensurate with the percentage of global births the country accounts for (18%), and represents a dramatic breakthrough for India, the WHO South-East Asia Region and the world.

Notably, India’s gender gap in child survival is now almost four times less than what it was five years ago, reflecting substantial advances in gender equity that the country can continue to build on, precisely as it has built on its successes in a range of other areas.

As India’s progress continues – including by concentrating on reducing neonatal deaths, which now account for 62% of under-five deaths – there is immense potential to go beyond ensuring children simply survive but can also thrive and enjoy their right to the highest attainable standard of health and wellbeing.

As outlined in the Global Strategy for Women’s, Children’s and Adolescents’ Health, among other priorities that means ensuring access to adequate nutrition and early childhood development services, at the same time as continuing to increase vaccination coverage for all. Ending preventable newborn and child deaths has been one of the WHO South-East Asia Region’s Flagship Priorities since 2014.

WHO is committed to supporting India and the Region consolidate the significant gains made in recent years, to accelerate further progress, and to ensure healthy lives and promote wellbeing for all at all ages.

Corporate Comm India(CCI NewsWire)

The Pharma Times News Bureau

Recent Posts

Bayer Introduces Bepanthen in India as New Survey Reveals Dry Skin Affects 1 in 2 Indians

·        World's no.1 skincare brand Bepanthen* launches in India, as a solution to tackle India's widespread dry skin…

7 hours ago

Lung Cancer in India: Understanding Risk Factors and the Importance of Early Detection

By Dr. Pavan Yadav, Lead Consultant - Interventional Pulmonology & Lung Transplantation, Aster RV Hospital.…

1 day ago

10 Winter Skin Care Tips Dermatologists Swear By

Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru  Winter weather brings a host…

4 days ago

Fighting Viral Hepatitis in India: Prevention, Risks, and the Path to Better Health

By Dr. Naveen Ganjoo, Senior Consultant - Hepatology & Integrated Liver Care, Aster RV Hospital…

5 days ago

Hon’ble Prime Minister Shri Narendra Modi Inaugurates LyfiusPharma’s Flagship Penicillin-G Facility at Kakinada, Andhra Pradesh

Under the Production Linked Incentive(PLI)scheme, Lyfius Pharma Private Limited(LyfiusPharma) invested ₹2,500 crores in Penicillin-G( Pen-G)facility…

6 days ago